CSIMarket


Quest Diagnostics Inc  (DGX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Quest Diagnostics Inc

DGX's Fundamental analysis








Quest Diagnostics Inc's sales fell by -1.93 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 852

Medical Laboratories industry recorded deterioration of revenues by -7.73 %

Quest Diagnostics Inc's net income grew by 76.72 % in IV. Quarter 2023 year on year, above company average,

More on DGX's Growth


Quest Diagnostics Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Company is currently trading with Price to Cash flow multiple of 38.32 in trailing twelve-month period.
Company
16.68
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 1.54.


More on DGX's Valuation
 
 Total Debt (Millions $) 4,713
 Dividend TTM ($) 2.76 $
 Dividend Yield TTM (%) 2.25 %
 Revenue/Employee (TTM) $ 188,816
 Net Income/Employee (TTM) $ 18,531
 Receivable Turnover (TTM) 7.43
 Tangible Book Value (Per Share $) -22.43

Quest Diagnostics Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Company is currently trading with Price to Cash flow multiple of 38.32 in trailing twelve-month period.
Company
16.68
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 1.54.

Quest Diagnostics Inc Price to Book Ratio is at 2.24 lower than Indusry Avg. of 436.21. and higher than S&P 500 Avg. of -2057.92

More on DGX's Valuation

  Market Capitalization (Millions $) 14,216
  Shares Outstanding (Millions) 114
  Employees 49,000
  Revenues (TTM) (Millions $) 9,252
  Net Income (TTM) (Millions $) 908
  Cash Flow (TTM) (Millions $) 371
  Capital Exp. (TTM) (Millions $) -408
  Total Debt (Millions $) 4,713
  Dividend TTM ($) 2.76 $
  Dividend Yield TTM (%) 2.25 %
  Revenue/Employee (TTM) $ 188,816
  Net Income/Employee(TTM) $ 18,531
  Receivable Turnover Ratio (TTM) 7.43
  Tangible Book Value (Per Share $) -22.43

  Market Capitalization (Millions $) 14,216
  Shares Outstanding (Millions) 114
  Employees 49,000
  Revenues (TTM) (Millions $) 9,252
  Net Income (TTM) (Millions $) 908
  Cash Flow (TTM) (Millions $) 371
  Capital Exp. (TTM) (Millions $) -408


    DGX's Profitability Comparisons
Quest Diagnostics Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in IV. Quarter 2023 to 11.67 % from 14.9 % in III. Quarter.

Quest Diagnostics Inc net profit margin of 8.96 % is currently ranking no. 9 in Medical Laboratories industry, ranking no. 80 in Healthcare sector and number 838 in S&P 500.


Profitability by Segment
Clinical laboratory testing business 16.67 %
All other operating segments 25.86 %



  Ratio
   Capital Ratio (MRQ) 1.43
  Total Debt to Equity (MRQ) 0.74
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.72
  Inventory Turnover Ratio (TTM) 33.15



Quest Diagnostics Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in IV. Quarter 2023 to 11.67 % from 14.9 % in III. Quarter.

Quest Diagnostics Inc net profit margin of 8.96 % is currently ranking no. 9 in Medical Laboratories industry, ranking no. 80 in Healthcare sector and number 838 in S&P 500.

More on DGX's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com